LIVE FROM THE DATABASETRANSACTIONS 362,114COMPANIES 5,761LATEST TRADE Oct 16UPDATED Oct 16, 09:12 PM
AVBPCIK 0001868279

ArriVent BioPharma, Inc.

10 transactions by 10 insiders, from December 10, 2025 to June 18, 2026.

Transactions
1010 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
$13.0Mopen market
Net
−$13.0Mnet selling

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Zhengbin YaoCEO1———
Kristine PetersonDir1———
Winston KungCFO1———
John HohnekerDir1———
Chris NoletDir1———
Merdad ParseyDir1———
James Paul KastenmayerGC1———
Robin LaChapelleCOO1———
Stuart LutzkerPres1———

Large holders and funds

Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.

InsiderTradesPlannedBoughtSold
HILLHOUSE INVESTMENT MANAGEMENT, LTD.10%1——$13.0M

All transactions

10 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Merdad ParseyDirDERIVJun 18A13,562$0.00—?
Kristine PetersonDirDERIVJun 18A13,562$0.00—?
John HohnekerDirDERIVJun 18A13,562$0.00—?
Chris NoletDirDERIVJun 18A13,562$0.00—?
Robin LaChapelleCOODERIVFeb 2A130,000$0.00—?
Stuart LutzkerPresDERIVFeb 2A150,000$0.00—?
Winston KungCFODERIVFeb 2A140,000$0.00—?
Zhengbin YaoCEODERIVFeb 2A550,000$0.00—?
James Paul KastenmayerGCDERIVFeb 2A130,000$0.00—?
HILLHOUSE INVESTMENT MANAGEMENT, LTD.10%JOINTDec 10S555,555$23.37$13.0M